MARKET

NERV

NERV

Minerva Neurosci
NASDAQ
1.631
+0.021
+1.31%
Closed 16:05 05/12 EDT
OPEN
1.680
PREV CLOSE
1.610
HIGH
1.740
LOW
1.590
VOLUME
3.91K
TURNOVER
0
52 WEEK HIGH
3.690
52 WEEK LOW
1.150
MARKET CAP
11.41M
P/E (TTM)
8.58
1D
5D
1M
3M
1Y
5Y
1D
*Minerva: FDA Interactions Continue for Complete Response Letter to NDA for Roluperidone for Negative Symptoms in Patients With Schizophrenia
Dow Jones · 9m ago
MINERVA NEUROSCIENCES REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND BUSINESS UPDATES
Reuters · 17m ago
*Minerva Neurosciences 1Q Loss $3.75M >NERV
Dow Jones · 17m ago
*Minerva Neurosciences 1Q Loss/Shr 50c >NERV
Dow Jones · 17m ago
Press Release: Minerva Neurosciences Reports First Quarter 2025 Financial Results and Business Updates
Dow Jones · 17m ago
Minerva Neurosciences Reports First Quarter 2025 Financial Results and Business Updates
Barchart · 5h ago
Minerva Neurosciences: Q1 Earnings Snapshot
Barchart · 5h ago
Weekly Report: what happened at NERV last week (0505-0509)?
Weekly Report · 1d ago
More
About NERV
More
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which is focused on the development and commercialization of proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. The Company is involved in developing roluperidone for the treatment of negative symptoms in patients with schizophrenia and has exclusive rights to develop and commercialize MIN-301 for the treatment of Parkinson’s disease. It has also co-developed seltorexant for the treatment of insomnia disorder and adjunctive treatment of major depressive disorder (MDD). Seltorexant is an innovative selective orexin 2 receptor antagonist. Its Roluperidone is a compound that has been shown to block serotonin, sigma, and α-adrenergic receptors that are involved in the regulation of mood, cognition, sleep and anxiety. Roluperidone has been designed to block a specific subtype of serotonin receptor called 5-HT2A.
Recently
Symbol
Price
%Change

Webull offers Minerva Neurosciences Inc stock information, including NASDAQ: NERV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NERV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NERV stock methods without spending real money on the virtual paper trading platform.